Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients.

Nadeau M, Boulay MÈ, Milot J, Lepage J, Bilodeau L, Maltais F, Boulet LP.

Respir Med. 2017 Apr;125:82-88. doi: 10.1016/j.rmed.2017.03.005. Epub 2017 Mar 6.

PMID:
28340867
2.

Ralstonia mannitolilytica in cystic fibrosis: A new predictor of worse outcomes.

Coman I, Bilodeau L, Lavoie A, Carricart M, Tremblay F, Zlosnik JE, Berthiaume Y.

Respir Med Case Rep. 2016 Dec 3;20:48-50. eCollection 2017.

3.

Postprandial fatty acid uptake and adipocyte remodeling in angiotensin type 2 receptor-deficient mice fed a high-fat/high-fructose diet.

Noll C, Labbé SM, Pinard S, Shum M, Bilodeau L, Chouinard L, Phoenix S, Lecomte R, Carpentier AC, Gallo-Payet N.

Adipocyte. 2015 Dec 8;5(1):43-52. doi: 10.1080/21623945.2015.1115582. eCollection 2016 Jan-Mar.

4.

Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 2: geometrical measurements in patients with functional mitral regurgitation.

Thériault-Lauzier P, Dorfmeister M, Mylotte D, Andalib A, Spaziano M, Blanke P, Martucci G, Lange R, Leipsic J, Bilodeau L, Piazza N.

EuroIntervention. 2016 Oct 10;12(8):e1021-e1030. doi: 10.4244/EIJY15M11_10.

5.

Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability.

Thériault-Lauzier P, Mylotte D, Dorfmeister M, Spaziano M, Andalib A, Mamane S, Chetrit M, Blanke P, Cecere R, Buithieu J, Martucci G, Tchetche D, Modine T, van Mieghem N, Lange R, Windecker S, Bilodeau L, Leipsic J, Piazza N.

EuroIntervention. 2016 Oct 10;12(8):e1011-e1020. doi: 10.4244/EIJY15M11_09.

6.

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC; LEADERS FREE Investigators.

N Engl J Med. 2015 Nov 19;373(21):2038-47. doi: 10.1056/NEJMoa1503943. Epub 2015 Oct 14.

7.

Randomized trial of primary PCI with or without routine manual thrombectomy.

Jolly SS, Cairns JA, Yusuf S, Meeks B, Pogue J, Rokoss MJ, Kedev S, Thabane L, Stankovic G, Moreno R, Gershlick A, Chowdhary S, Lavi S, Niemelä K, Steg PG, Bernat I, Xu Y, Cantor WJ, Overgaard CB, Naber CK, Cheema AN, Welsh RC, Bertrand OF, Avezum A, Bhindi R, Pancholy S, Rao SV, Natarajan MK, ten Berg JM, Shestakovska O, Gao P, Widimsky P, Džavík V; TOTAL Investigators.

N Engl J Med. 2015 Apr 9;372(15):1389-98. doi: 10.1056/NEJMoa1415098. Epub 2015 Mar 16.

8.

Transcatheter heart valve failure: a systematic review.

Mylotte D, Andalib A, Thériault-Lauzier P, Dorfmeister M, Girgis M, Alharbi W, Chetrit M, Galatas C, Mamane S, Sebag I, Buithieu J, Bilodeau L, de Varennes B, Lachapelle K, Lange R, Martucci G, Virmani R, Piazza N.

Eur Heart J. 2015 Jun 1;36(21):1306-27. doi: 10.1093/eurheartj/ehu388. Epub 2014 Sep 28. Review.

PMID:
25265974
9.

First-in-human experience with the Medtronic CoreValve Evolut R.

Piazza N, Martucci G, Lachapelle K, de Varennes B, Bilodeau L, Buithieu J, Mylotte D.

EuroIntervention. 2014 Mar 20;9(11):1260-3. doi: 10.4244/EIJV9I11A215.

10.

Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators.

N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18.

11.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.

12.

Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial.

Machaalany J, Bilodeau L, Hoffmann R, Sack S, Sievert H, Kautzner J, Hehrlein C, Serruys P, Sénéchal M, Douglas P, Bertrand OF.

Am Heart J. 2013 May;165(5):761-9. doi: 10.1016/j.ahj.2013.01.010. Epub 2013 Feb 14.

PMID:
23622913
13.

Saphenous vein graft perforation during percutaneous coronary intervention: a case series.

Marmagkiolis K, Brilakis ES, Hakeem A, Cilingiroglu M, Bilodeau L.

J Invasive Cardiol. 2013 Mar;25(3):157-61.

14.

Current percutaneous treatment strategies for saphenous vein graft disease.

Marmagkiolis K, Grines C, Bilodeau L.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):406-13. doi: 10.1002/ccd.24554. Epub 2013 Jun 5. Review.

PMID:
22777812
15.

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.

Abizaid A, Costa JR Jr, Banning A, Bartorelli AL, Dzavik V, Ellis S, Gao R, Holmes DR Jr, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Orlick A, Spaulding C, Worthley S, Urban PM; e-SELECT Investigators.

JACC Cardiovasc Interv. 2012 Jan;5(1):64-71. doi: 10.1016/j.jcin.2011.09.016.

16.

Comparative clinical and airway inflammatory features of asthmatics with or without polyps.

Bilodeau L, Boulay ME, Prince P, Boisvert P, Boulet LP.

Rhinology. 2010 Dec;48(4):420-5. doi: 10.4193/Rhino09.095.

PMID:
21442078
17.

Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry.

Urban P, Abizaid A, Banning A, Bartorelli AL, Baux AC, Džavík V, Ellis S, Gao R, Holmes D, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Worthley S; e-SELECT Investigators.

J Am Coll Cardiol. 2011 Mar 29;57(13):1445-54. doi: 10.1016/j.jacc.2010.11.028.

18.

Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?

Gallo-Payet N, Guimond MO, Bilodeau L, Wallinder C, Alterman M, Hallberg A.

Front Endocrinol (Lausanne). 2011 Aug 26;2:17. doi: 10.3389/fendo.2011.00017. eCollection 2011.

19.

Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial.

Haeck JD, Koch KT, Gu YL, Bilodeau L, Kuijt WJ, Sjauw KD, Henriques JP, Baan J, Vis MM, Verouden NJ, Groenink M, Piek JJ, Tijssen JG, Krucoff MW, Zijlstra F, de Winter RJ.

Neth Heart J. 2010 Nov;18(11):531-6.

20.

Computer-assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast-enhanced cardiovascular magnetic resonance outcomes in patients with ST-segment elevation myocardial infarction.

Gu YL, Haeck JD, Vogelzang M, Bilodeau L, Krucoff MW, Tijssen JG, de Winter RJ, Zijlstra F, Koch KT.

Catheter Cardiovasc Interv. 2011 Feb 1;77(2):174-81. doi: 10.1002/ccd.22665.

PMID:
20518003

Supplemental Content

Loading ...
Support Center